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Few examples of new heterocyclic 1-deazapyrimido[1,2,3-cd]purine derivatives were synthesized 
by intramolecular cyclization of methyl 7-(oxiran-2-ylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-6-
carboxylates. The latter were obtained by iodolactonization of 7-allylpyrrolo[2,3-d]pyrimidine-6-
carboxylic acids. 
________________________________________________________________________________ 
Introduction 
Pyrimidine and purine rings are widely 
spread in nature and are the basis of numerous 
biologically active substances. Condensed 
pyrimidine compounds are thus of high interest 
both in organic and in pharmaceutical chemistry 
[1,2], and the search for new or improved  
approaches to synthesize these compounds is a 
highly relevant task. 
Among tricyclic purine derivatives, the 
compounds in which the third ring is connected 
to the N3 and N9 atoms of the purine motif are 
particularly interesting [3,4]. A natural 
pyrimido[1,2,3-cd]purine-8,10(9H)-dione was 
for example isolated from the South China Sea 
gorgonian Subergorgia suberosa [5]. Tricyclic 
xanthine derivatives were described as selective 
adenosine A1 receptor antagonists (PSB-63) [6-
8], and purine cyclonucleosides modified with 
sugar residues were reported to exhibit antiviral 
properties [9-11].  
Synthesis of tricyclic derivatives having 
pyrrolo[2,3-d]pyrimidine (7-deazapurine) 
moiety in which the third ring comprises the 
nitrogen atoms of pyrrole and pyrimidine units 
has been described back in 1963 [12]. No other 
examples of such systems in literature This 
compound is to the best of our knowledge the 
sole example of such derivatives described in 
the literature. In the present work we propose a 
convenient approach for the synthesis of the 
new tricyclic 1-deazapyrimido[1,2,3-cd]purine 
moiety (4,5-dihydro-3H-2a,7-diaza-5a-
azoniaacenaphthylene). This method is based on 
the use of an intramolecular cyclisation of 
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pyrrolo[2,3-d]pyrimidine derivatives substituted 
in the position 7. 
 
Results and discussion 
The synthesis of the targeted 10-amino-
5-hydroxy-5,6-dihydro-4H-1-deazapyrimido-
[1,2,3-cd]purin-7-ium salts 6 was performed 
according to Scheme 1. Starting reactants were 
the previously reported 4-aminosubstituted 7-
allylpyrrolo[2,3-d]pyrimidine-6-carboxylic 
acids 1a, b [13]. Interaction of 1a, b with iodine 
led to the formation of the iodolactonization 
products 8-iodomethylpyrimido [5',4':4,5] 
pyrrolo[2,1-с][1,4]oxazines 2a, b. 
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Scheme 1. Synthesis of 5,6-dihydro-4H-1-deazapyrimido[1,2,3-cd]purin-7-ium salts 6a-d. 
 
The structure of compounds 2a,b was easily 
confirmed by conventional NMR analysis. The 
characteristic signal of the CH2I group in the 
1H 
NMR spectra appeared as two doublet of 
doublets at 3.59, 4.04 ppm and 3.65, 4.07 ppm, 
and the signal of the adjacent aliphatic CH 
resonated at 4.88-4.93 ppm. In the 13C NMR 
spectra, the signal of the C-8 atom appears at 
76.7 ppm, and the signal of the iodomethyl 
carbon atom resonates at 4.5 ppm. Moreover, a 
comparison of the spectral characteristics of the 
pyrimido[5',4':4,5]pyrrolo[2,1-с][1,4]oxazines 
2a,b with those of the known relative 
compounds such as the 3-iodomethyl-3,4-
dihydro-1H-2-benzopyran-1-one [14, 15] and 
the 3-iodomethyl-3,4-dihydro-1H-[1,4]oxazino 
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[4,3-a]indol-1-one [16], allowed to confirm the 
formation of the lactone cycle.  
Treatment of the oxazines 2a, b with 
sodium methylate led to a nucleophilic attack at 
the carbonyl group with the simultaneous 
lactone cycle splitting, possibly inducing the 
formation of intermediates 3a, b. The latter 
undergo a cyclisation reaction, thus leading to 
the formation of the methyl 7-(oxiran-2-
ylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-6-
carboxylates 4a, b. The heating of 4a, b in 
acetonitrile in the presence of 
triethylammonium chloride (or bromide) 
induces the opening of the oxirane cycle, thus 
giving the intermediates 5a-с, which finally give 
new 5,6-dihydro-4H-1-deazapyrimido[1,2,3-
cd]purin-7-ium salts 6a-d after an 
intramolecular cyclisation. 
The formation of the compounds 6 was 
previously described [17-19] by reaction of 
adenine derivatives with epichlorohydrin, but 
the low selectivity of the adenine alkylation 
process allowed the isolation of only small 
quantities of such quaternarized compounds. 
The formation of quaternary salts was also 
reported by alkylation of 7-azaindole [20], 1-
deazapurine [21], adenine [22, 23], indolo[2,3-
b]quinoxaline [24]. 
To synthesize the 2-unsubstitutеd 1-
deazapyrimido[1,2,3-cd]purin-7-ium salt, the 
compound 6c was subjected to acidic hydrolysis 
to form the carboxylic acid 7. The 
decarboxylation of 7 led to the unsubstituted 
tricyclic salt 8 (Scheme 2). It is worth noting 
that compound 8 can be directly prepared from 
the salt 6c by refluxing in a 6N HCl solution. 
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Scheme 2. Synthesis of 5,6-dihydro-4H-1-deazapyrimido[1,2,3-cd]purin-7-ium salt 8. 
 
Heteroaromatic salts containing 
imidazolium, pyridinium or isoquinolinium 
rings have been described as inhibitors of 
acetylcholinesterase (AChE) [25, 26]. AChE 
catalyzes the hydrolysis of acetylcholine and 
plays a key role in the termination of the 
transmission of nerve impulses. 
Acetylcholinesterase inhibitors are used in 
treatment of neurodegenerative diseases 
including Alzheimer's disease. The inhibitory 
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activity of the 1-deazapyrimido[1,2,3-cd]purine 
derivatives described in this paper against 
AChE was thus evaluated. Previously obtained 
results showed that these compounds can inhibit 
AChE, with IC50 values in the micromolar 
range. 
Conclusions 
An effective method for the synthesis of 
new tricyclic derivatives exhibiting a 
pyrrolo[2,3-d]pyrimidine (7-deazapurine) core 
was developed. The application of this approach 
to the synthesis of the 1-deazapyrimido[1,2,3-
cd]purine (4,5-dihydro-3H-2a,7-diaza-5a-
azoniaacenaphthylene) derivative was 
described.  
 
Experimental part 
The 1H NMR spectra were obtained on Bruker 
Avance DRX-500 (500 MHz) and Varian Unity 
plus 400 (400 MHz) using solutions in DMSO-
d6.  The 
13C NMR spectra were recorded in 
DMSO-d6 solutions on Bruker Avance DRX-
500 (125 MHz) spectrometer. The spectra were 
referenced relative to internal TMS. APT 
experiments were used to assign 13C chemical 
shifts. Elemental analysis was carried out in the 
analytical laboratory of IBOPC NASU. 
Monitoring of the reaction progress and purity 
of the synthesized compounds was performed 
by TLC on Silufol UV-254 plates.  
 
Constant values for 7-allyl-4-(dimethylamino)-
7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid 
1a are given in [13]. 
7-Allyl-4-morpholin-4-yl-7H-pyrrolo[2,3-
d]pyrimidine-6-carboxylic acid 1b was 
synthesized according to [13]. It was isolated as 
a white powder with 73% yield; mр 224-226оС 
(dec). 1Н NMR (400 MHz, DMSO-d6), δ: 3.72-
3.74 (4H, m, N(CH2)2 morpholine), 3.89-3.91 
(4H, m, O(CH2)2 morpholine), 4.69 (1H, d, J 
17.6) and 5.01 (1H, d, J 10.4, NCH2CH=CH2), 
5.15-5.17 (2H, m, NCH2); 5.93-6.01 (1H, m, 
NCH2CH=CH2), 7.46 (1H, s, H-5), 8.29 (1H, s, 
H-2), 13.12 (1H, br s, OH); 13C NMR (125 
MHz, DMSO-d6), δ: 45.1, 45.8 (N(CH2)2 
morpholine and NCH2), 66.5 (O(CH2)2 
morpholine), 101.8 (C), 111.4 (C-5), 115.9 
(NCH2CH=CH2), 125.0 (C), 135.2 
(NCH2CH=CH2), 153.3 (CH), 153.8 (C), 157.8 
(C), 162.7 (C).  Anal. calcd for C14H16N4O3: C, 
58.33; H, 5.59; N, 19.43. Found: C, 58.39; H, 
5.50; N, 19.38. 
4-(Dimethylamino)-8-(iodomethyl)-8,9-dihydro-
6H-pyrimido[5',4':4,5]pyrrolo[2,1-
с][1,4]oxazin-6-one (2a). A mixture of 7-
allylpyrrolo[2,3-d]pyrimidine-6-carboxylic acid 
1a (4.9 g, 20 mmol), iodine (10.15 g, 40 mmol), 
and sodium acetate (6.56.2 g, 80 mmol) in 
acetic acid (50 mL) was heated under stirring 
for 10h at 100оС. The formed precipitate was 
separated by filtration. It was treated with a 
0.1N solution of Na2S2O3 (100 ml), and then 
with a saturated solution of NaHCO3 at 50-60
оС 
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for 30 min. The precipitate was once more 
separated by filtration, washed with water and 
recrystallized from acetonitrile. Yield 6.14 g, 
83% as a white crystals; mр 184-186оС. 1Н 
NMR (400 MHz, DMSO-d6), δ: 3.25-3.37 (6H, 
m, N(CH3)2), 3.59 (1H, dd, J 11.2, 6.4 Hz), 3.65 
(1H, dd, J 4.8, 11.2 Hz, CH2I), 4.03 (1H, dd, J 
12.8, 10.8 Hz), 4.73 (1H, dd, J 2.4, 12.8 Hz, 
NCH2), 4.88-4.90 (1H, m, CH), 7.53 (1H, s, H-
5), 8.26 (1H, s, H-2); 13C NMR (125 MHz, 
DMSO-d6), δ: 4.5 (CH2I), 43.2 (NCH2), 76.7 
(CH), 103.7 (C), 110.6 (C-5), 119.1 (C), 150.5 
(C), 154.7 (C-2), 158.1 (C), 158.6 (C). The 
signal of N(CH3)2 overlaps with DMSO. Anal. 
calcd for C12H13IN4O2: C, 38.73; H, 3.52; I, 
34.10; N, 15.05. Found: C, 38.79; H, 3.47; I, 
34.18; N, 15.15. 
8-(Iodomethyl)-4-morpholin-4-yl-8,9-dihydro-
6H-pyrimido[5',4':4,5]pyrrolo[2,1-
с][1,4]oxazin-6-one (2b) was obtained 
analogously as 2а. Yield 78% as white crystals; 
mр 173-175оС (dec). 1Н NMR (400 MHz, 
DMSO-d6), δ: 3.58-3.74 (6H, m, N(CH2)2 
morpholine and CH2I), 3.89-3.93 (4H, m, 
O(CH2)2 morpholine), 4.04 (1H, dd, J 11.4, 6.2 
Hz), 4.07 (1H, dd, J 5.8, 11.4 Hz, CH2I), 4.73 
(1H, dd, J 12.6, 10.6 Hz), 4.76 (1H, dd, J 2.6, 
12.6 Hz, NCH2), 4.90-4.93 (1H, m, CH), 7.64 
(1H, s, H-5), 8.32 (1H, s, H-2); 13C NMR (125 
MHz, DMSO-d6), δ: 4.5 (CH2I), 43.2 (NCH2), 
45.9 (N(CH2)2 morpholine), 66.5 (O(CH2)2 
morpholine), 76.7 (CH), 103.4 (C), 109.6 (C-5), 
119.8 (C), 150.9 (C), 154.4 (C-2), 157.8 (C), 
158.5 (C). Anal. calcd for C14H15IN4O3: C, 
40.60; H, 3.65; I, 30.64; N, 13.53. Found: C, 
40.58; H, 3.70; I, 30.69; N, 13.47. 
Methyl 4-(dimethylamino)-7-(oxiran-2-
ylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-6-
carboxylate (4a). A mixture of oxazine 2а (3.72 
g, 10 mmol) and MeONa (0.54 g, 10 mmol) in 
methanol (30 mL) was stirred for 30 min at 20-
25оС. The solvent was evaporated under 
vacuum, and the residue was treated with water 
(20 ml). The precipitate was separated by 
filtration and recrystallized from methanol. 
Yield 2.00 g, 73% as white crystals; mр 125-
127оС (dec). 1Н NMR (400 MHz, DMSO-d6), δ: 
2.36 (1H, dd, J 4.4, 2.4 Hz) and 2.67 (1H, dd, J 
4.0, 4.4 Hz, CH2O), 3.27-3.34 (7H, m, N(CH3)2, 
CH), 3.85 (1H, s, OCH3), 4.68 (1H, dd, J 14.0, 
4.8 Hz) and 4.76 (1H, dd, J 4.4, 14.0 Hz, 
NCH2), 7.42 (1H, s, H-5), 8.24(1H, s, H-2); 
13C 
NMR (125 MHz, DMSO-d6), δ: 44.3 (СН2O), 
45.4 (NСН2), 50.4 (СН), 52.1 (OCH3), 102.1 
(С), 111.6 (C-5), 123.6 (C), 153.3 (C), 154.1 
(C-2), 158.1 (C), 161.6 (C). The signal of 
N(CH3)2 overlaps with DMSO. Anal. calcd for 
C13H16N4O3: C, 56.51; H, 5.84; N, 20.28. 
Found: C, 56.61; H, 5.79; N, 20.36. 
Methyl 4-morpholin-4-yl-7-(oxiran-2-ylmethyl)-
7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate 
(4b) A mixture of oxazine 2b (4.14 g, 10 mmol) 
and MeONa (0.54 g, 10 mmol) in methanol (50 
mL) was stirred for 1 hr at 20-25оС. The formed 
precipitate was separated by filtration, washed 
with water and recrystallized from acetonitrile. 
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Yield 2.7 g, 85% as white crystals; mр 156-
158оС (dec). 1Н NMR (400 MHz, DMSO-d6), δ: 
2.35 (1H, dd, J 4.0, 2.2 Hz), 2.67 (1H, dd, J 3.8, 
4.0 Hz, CH2O), 3.73-3.81 (4H, m, N(CH2)2 
morpholine), 3.84-3.91 (7H, m, O(CH2)2 
morpholine and OCH3), 4.71 (1H, dd, J 14.4, 4.8 
Hz), 4.78 (1H, dd, J 4.4, 14.4 Hz, NCH2), 7.50 
(1H, s, H-5), 8.30(1H, s, H-2); 13C NMR (125 
MHz, DMSO-d6), δ: 44.3 (СН2O), 45.4, 45.9 
(N(CH2)2 morpholine and NCH2), 50.4 (СН), 
52.2 (OCH3), 66.4 (O(CH2)2 morpholine), 101.9 
(С), 110.6 (C-5), 124.3 (C), 153.8 (C), 154.1 
(C-2), 157.9 (C), 161.5 (C). Anal. calcd for 
C15H18N4O4: C, 56.60; H, 5.70; N, 17.60. 
Found: C, 56.69; H, 5.81; N, 20.16. 
General procedure for the preparation of 5,6-
dihydro-4H-1-deazapyrimido[1,2,3-cd]purin-7-
ium salts 6a-d. A mixture of one of the 
compounds 4а,b (5 mmol) and 
triethylammonium chloride (bromide) (10 
mmol) in acetonitrile (30 ml) was refluxed for 
3-5 h. The formed precipitate was separated by 
filtration. To form compounds 6с,d, the 
precipitated salts were dissolved in water (20 
ml) and a saturated solution of NaClO4 (5 ml) 
was added. The formed precipitate was 
separated by filtration and washed with water. 
8-(Dimethylamino)-4-hydroxy-2-
(methoxycarbonyl)-4,5-dihydro-3H-2a,7-diaza-
5a-azoniaacenaphthylene chloride (6a). Yield 
78% as white crystals; mр 213-215оС (dec). 1Н 
NMR (400 MHz, DMSO-d6), δ: 3.44 (3H, s, 
NCH3), 3.58 (3H, s, NCH3), 3.89 (1H, s, OCH3), 
4.30-4.59 (2H, m, NCH2), 4.44-4.47 (1H, m) 
and 4.30-4.59 (2H, m, NCH2, CH), 5.94-5.98 
(1H, m, OH), 7.69 (1H, s, H-1), 8.76 (1H, s, H-
6); 13C NMR (125 MHz, DMSO-d6), δ: 39.8 
(NCH3), 41.0 (NCH3), 50.1 (NСН2), 50.6 
(NСН2), 52.7 (OCH3), 59.2 (CH), 100.7 (C), 
113.2 (C-1), 125.5 (C), 138.3 (C), 147.5 (C-6), 
156.9 (C), 160.6 (C). Anal. calcd for 
C13H18ClN4O3: C, 49.76; H, 5.78; Cl, 11.30; N, 
17.86. Found: 49.68; H, 5.82; Cl, 11.30; N, 
17.93. 
8-(Dimethylamino)-4-hydroxy-2-
(methoxycarbonyl)-4,5-dihydro-3H-2a,7-diaza-
5a-azoniaacenaphthylene bromide (6b). Yield 
71% as white crystals; mр 2214-223оС (dec). 1Н 
NMR (400 MHz, DMSO-d6), δ: 3.45 (3H, s, 
NCH3), 3.59 (3H, s, NCH3), 3.90 (1H, s, OCH3), 
4.32-4.36 (2H, m, NCH2), 4.37-4.44 (1H, m) 
and 4.66-4.69 (2H, m, NCH2, CH), 5.82-5.85 
(1H, m, OH), 7.69 (1H, s, H-1), 8.78 (1H, s, H-
6); 13C NMR (125 MHz, DMSO-d6), δ: 39.8 
(NCH3), 41.2 (NCH3), 50.2 (NСН2), 50.6 
(NСН2), 52.8 (OCH3), 59.2 (CH), 100.7 (C), 
113.0 (C-1), 125.5 (C), 138.3 (C), 147.6 (C-6), 
157.0 (C), 160.6 (C). Anal. calcd for 
C13H18BrN4O3: C, 43.59; H, 5.06; Br, 22.31; N, 
15.64. Found: 43.64; H, 5.09; Br, 22.41; N, 
15.71 
8-(Dimethylamino)-4-hydroxy-2-
(methoxycarbonyl)-4,5-dihydro-3H-2a,7-diaza-
5a-azoniaacenaphthylene perchlorate (6c). 
Yield 82% as white crystals; mр 200-202оС. 1Н 
NMR (400 MHz, DMSO-d6), δ: 3.45 (3H, s, 
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NCH3), 3.59 (3H, s, NCH3), 3.90 (1H, s, OCH3), 
4.29-4.44 (3H, m) and 4.66-4.69 (2H, m, 
2NCH2, CH), 5.82-5.83 (1H, m, OH), 7.70 (1H, 
s, H-1), 8.73(1H, s, H-6). Anal. calcd for 
C13H18ClN4O7: C, 41.33; H, 4.80; Cl, 9.38; N, 
14.83. Found: 41.37; H, 4.76; Cl, 9.45; N, 
14.89. 
4-Hydroxy-2-(methoxycarbonyl)-8-morpholin-
4-yl-4,5-dihydro-3H-2a,7-diaza-5a-
azoniaacenaphthylene perchlorate (6d). Yield 
74% as white crystals; mр 191-193оС (dec). 1Н 
NMR (400 MHz, DMSO-d6), δ: 3.75-3.83 (4H, 
m, N(CH2)2 morpholine), 3.91 (1H, s, OCH3), 
4.11-4.15 (7H, m, O(CH2)2 morpholine), 4.31-
4.37 (2H, m, NCH2), 4.43-4.46 (1H, m) and 
4.67-4.69 (2H, m, NCH2, CH), 5.83-5.85 (1H, 
m, OH), 7.82 (1H, s, H-1), 8.77 (1H, s, H-6); 
Anal. calcd for C15H20ClN4O8: C, 42.92; H, 
4.80; Cl, 8.44; N, 13.35. Found: 42.85; H, 4.85; 
Cl, 8.51; N, 13.39. 
2-Carboxy-8-(dimethylamino)-4-hydroxy-4,5-
dihydro-3H-2a,7-diaza-5a-
azoniaacenaphthylene perchlorate (7). A 
suspension of 6с (0.38 g, 1 mmol) in 8N 
hydrochloric acid (3 ml) was refluxed for 30 
min, and then was left for 12 h at 20-25оС. The 
formed precipitates was separated by filtration, 
washed with water and recrystallized from 
water. Yield 0.27 g, 75% as white crystals; mр 
232-234оС (dec). 1Н NMR (500 MHz, DMSO-
d6), δ: 3.43 (3H, s, NCH3), 3.57 (3H, s, NCH3), 
4.29-4.32 (2H, m, NCH2), 4.39-4.42 (1H, m) 
and 4.68-4.71 (2H, m, NCH2, CH), 5.77-5.80 
(1H, m, OH), 7.62 (1H, s, H-1), 8.71 (1H, s, H-
6); 13.71 (1H, br s, OH); 13C NMR (125 MHz, 
DMSO-d6), δ: 39.7 (NCH3), 41.1 (NCH3), 50.1 
(NСН2), 50.6 (NСН2), 59.5 (CH), 100.7 (C), 
110.3 (C-1), 130.5 (C), 137.6 (C), 146.6 (C-6), 
156.9 (C), 162.1 (C). Anal. calcd for 
C12H16ClN4O7: C, 39.62; H, 4.43; Cl, 9.75; N, 
15.40. Found: 39.72; H, 4.46; Cl, 9.83; N, 
15.46. 
8-(Dimethylamino)-4-hydroxy-4,5-dihydro-3H-
2a,7-diaza-5a-azoniaacenaphthylene 
perchlorate (8).  
Method A. A suspension of 7 (0.18 g, 0.5 
mmol) in 6N hydrochloric acid (3 ml) was 
refluxed for 2 h, and left for 12 h at 20-25оС. 
The formed precipitate was separated by 
filtration, washed with water and recrystallized 
from water. Yield 0.1 g, 63% as a white 
crystals; mр 155-157оС.  
Method B. A suspension of 6c (0.19 g, 0.5 
mmol) in 6N hydrochloric acid (5 ml) was 
refluxed for 6 h, and left for 12 h at 20-25оС. 
The formed precipitates was separated by 
filtration, washed with water and recrystallized 
from water. Yield 0.08 g, 50% as a white 
crystals; mр 155-157оС.  
The characteristics of the compound 8 obtained by 
both methods are identical. 1Н NMR (500 MHz, 
DMSO-d6), δ: 3.37 (3H, s, NCH3), 3.52 (3H, s, 
NCH3), 4.22-4.29 (2H, m, NCH2), 4.34-4.47 
(2H, m, NCH2), 4.64-4.66 (1H, m, CH), 5.89-
5.91 (1H, m, OH), 6.97 (1H, d, J 2.2 Hz, H-1), 
7.52 (1H, d, J 2.2 Hz, H-2), 8.67 (1H, s, H-6); 
13C NMR (125 MHz, DMSO-d6), δ: 39.2 
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(NCH3), 41.0 (NCH3), 49.4 (NСН2), 50.7 
(NСН2), 59.4 (CH), 101.4 (C), 104.6 (C-1), 
126.2 (C-2), 136.2 (C), 145.1 (C-6), 156.6 (C). 
Anal. calcd for C11H16ClN4O5: C, 41.32; H, 
5.04; Cl, 11.09; N, 17.52. Found: 41.40; H, 
5.08; Cl, 11.12; N, 17.59. 
 
References 
[1] Rybár A. Annulated Heterocyclo-
Purines II: Fused Six- and More-Membered Heterocyclo-
Purinediones, Purinones and Purineimines. Adv. 
Heterocycl. Chem. 2005; 88: 175–229. 
[2] Szymańska E., Mazurkiewicz J., Kieć-
Kononowicz K. Methods for the synthesis of xanthine-
derived polycyclic fused systems. Heterocycl. Commun., 
2013; 19(5): 297-310. 
[3] Šimo O., Rybár A., Alföldi J. New 
[c,d]-Fused Purinediones: 2-Substituted 9-Methyl-4,5-
dihydro-6H,8H-pyrimido-[1,2,3-cd]purine-8,10(9H)-
diones. Synthesis 1995; 1995(7): 837-840. 
[4] Šimo O., Rybár A., Alföldi J. 2-
Triazolylpyrimido[1,2,3-cd]purine-8,10-diones via 1,3-
dipolar cycloadditions to 2-ethynylpyrimido[1,2,3-
cd]purine-8,10-dione. J. Heterocycl. Chem. 2000; 37(5): 
1033-1039. 
[5] Qi S.-H., Zhang S., Gao C.-H., Li Q.-X. 
Purine and Pyrimidine Derivatives from the South China 
Sea Gorgonian Subergorgia suberosa. Chem. Pharm. 
Bull. 2008; 56(7): 993-994. 
[6] Weyler S., Hayallah A.M., Müller C.E. 
Versatile, convenient synthesis of pyrimido[1,2,3-
cd]purinediones. Tetrahedron 2003; 59(1): 47-54. 
[7] Burbiel J.C., Hockemeyer J., Müller 
C.E. Microwave-assisted ring closure reactions: Synthesis 
of 8-substituted xanthine derivatives and related 
pyrimido- and diazepinopurinediones. Beilstein J. Org. 
Chem. 2006; 2(20): 1-7. 
[8] Weyler S., Fülle F., Diekmann M., 
Schumacher B., Hinz S., Klotz K.-N., Müller C.E. 
Improving Potency, Selectivity, and Water Solubility of 
Adenosine A1 Receptor Antagonists: Xanthines Modified 
at Position 3 and Related Pyrimido[1,2,3-cd]purinediones. 
ChemMedChem 2006; 1(8): 891-902. 
[9] Mieczkowski A., Roy V., Agrofoglio 
L.A. Preparation of Cyclonucleosides. Chem. Rev. 2010; 
110(4): 1828-1856. 
[10] Kikugawa K. Transformation of 
Adenosine into N3, 3'- and N3, 5'-Cycloadenosines via 
the Reactions with Sulfuryl Chloride and Thionyl 
Chloride. Chem. Pharm. Bull. 1977; 25(9): 2181-2188. 
[11] Carvalho G., Fourrey J.-L., Dodd R.H., 
Silva A.D. Synthesis of a 4′,4′-spirothietane-2′, N3-
cycloadenosine as a highly constrained analogue of 5′-
deoxy-5′-methylthioadenosine (MTA). Tetrahedron Lett. 
2009; 50(4): 463-466. 
[12] Mizuno Y., Ikehara M., Watanabe K.A., 
Suzaki S., Itoh T. Synthetic Studies of Potential 
Antimetabolites. IX. The Anomeric Configuration of 
Tubercidin. J. Org. Chem. 1963; 28(12): 3329-3331. 
[13] Verves E.V., Kucher A.V., Muzychka 
L.V., Smolii O.B. Synthesis of 7-alkyl-4-amino-7H-
pyrrolo-[2,3-d]pyrimidine-6-carboxylic acids. Chem. 
Heterocycl. Compounds 2013; 48(12): 1844–1852. 
[14] Grunewald G.L., Dahanukar V.H. 
Synthesis of 3-alkyl-8-substituted- and 4-hydroxy-8-
substituted-2,3,4,5-tetrahydro-1H-2-benzazepines. J. 
Heterocycl. Chem. 1994; 31(6): 1609-1617. 
[15] Roux M.-C., Paugam R., Rousseau G. 
Evaluation of exo-endo Ratios in the Halolactonization of 
ω-Unsaturated Acids. J. Org. Chem. 2001; 66(12): 4304-
4310. 
[16] Putey A., Fournet G., Joseph B. General 
and Easy Access to 11-Substituted 4-Hydroxy-2,3,4,5-
tetrahydro[1,4]diazepino[1,2-a]indol-1-one Derivatives. 
Synlett 2006; 17: 2755-2758. 
FRENCH-UKRAINIAN JOURNAL OF CHEMISTRY (2017, VOLUME 05, ISSUE 02)  
23 
 
[17] Seden T.P., Turner R.W. The reaction of 
adenine with epichlorohydrin. J. Heterocycl. Chem. 1975; 
12(5): 1045-1046. 
[18] Harriman G.C., Poirot A.F., Abushanab 
E., Midgett R.M., Stoeckler J.D. Adenosine deaminase 
inhibitors. Synthesis and biological evaluation of C1' and 
nor-C1' derivatives of (+)-erythro-9-[2(S)-hydroxy-3(R)-
nonyl]adenine. J. Med. Chem., 1992, 35(22): 4180-4184. 
[19] Sund P., Kronberg L. Ring-opening of 
3--d-ribofuranosyl-3,7,8,9-tetrahydropyrimido[1,2-
i]purin-8-ol and preparation of 2-thio- and 2-aza-
adenosine derivatives. Nucleosides, Nucleotides and 
Nucleic Acids, 2008, 27: 1215-1226. 
[20] Robison M.M., Butler F.P., Robison 
B.L. 7-Azaindole. IV. The Hydrogenation of 7-Azaindole 
and Related Compounds. J. Am. Chem. Soc., 1957, 
79(10): 2573-2578. 
[21] Savarino P., Viscardi G., Barni E., 
Modica G.D. Quaternary salts and polymethine dyes from 
2-(methylpyridyl)-X-azolo[4,5-b]pyridine. J. Heterocycl. 
Chem., 1987; 24(4): 1053-1060. 
[22] Holy A. Preparation of aliphatic 
analogues of S-adenosyl-L-homocysteine and related 
compounds. Collect. Czech. Chem. Commun., 1981, 46: 
3134-3144. 
[23] Kim M.S., Gokel G.W. A molecular 
box, based on bibracchial lariat ethers having adenine and 
thymine sidearms, that self-assembles in water. J. Chem. 
Soc., Chem.Commun., 1987, 22: 1686-1688. 
[24] Shibinskaya M.O., Kutuzova N.A., 
Mazepa A.V., Lyakhov S.A., Andronati S.A., Zubritsky 
M.J., Galat V.F., Lipkowski J., Kravtsov V.Ch. Synthesis 
of 6-Aminopropyl-6H-indolo[2,3-b]quinoxaline 
Derivatives. J. Heterocycl. Chem., 2012; 49(3): 678-682. 
[25] Sundberg R.J., Dalvie D., Cordero J., 
Sabat M., Musallam H.A. Carbamates of 
(hydroxyphenoxy)methylheteroaromatic salts as 
acetylcholinesterase inhibitors and protective agents 
against organophosphorus compounds. Chem. Res. 
Toxicol., 1993; 6(4): 500-505. 
[26] Parlar S., Bayraktar G., Tarikogullari 
A.H., Alptüzün V., Erciyas E. Synthesis, Biological 
Evaluation and Molecular Docking Study of Hydrazone-
Containing PyridiniumSalts as Cholinesterase Inhibitors. 
Chem. Pharm. Bull., 2016; 64(9):1281-1287. 
 
 
  
